Paul T. Thevenot, Ph.D. - Publications

Affiliations: 
2010 Biomedical Engineering University of Texas at Arlington, Arlington, TX, United States 
Area:
Biomedical Engineering, Immunology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mohamed E, Sierra RA, Trillo-Tinoco J, Cao Y, Innamarato P, Payne KK, de Mingo Pulido A, Mandula J, Zhang S, Thevenot P, Biswas S, Abdalla SK, Costich TL, Hänggi K, Anadon CM, et al. The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling. Immunity. 52: 668-682.e7. PMID 32294407 DOI: 10.1016/J.Immuni.2020.03.004  0.344
2020 Truong T, Ramalingam V, Morris T, Gimenez J, Gulotta P, Thevenot P, Nunez K, Gilbert P, Marsala A, Tramel R, Galliano G, Cohen A, Kay D, Sandow T. 3:54 PM Abstract No. 233 Immune status correlates with locoregional treatment response, new tumor development, and tumor necrosis in patients with hepatocellular carcinoma Journal of Vascular and Interventional Radiology. 31. DOI: 10.1016/J.Jvir.2019.12.276  0.304
2019 Sandow T, Nunez K, Gimenez J, Ramalingam V, Gulotta P, Robertson S, Gilbert P, Marsala A, DeVun D, Kay D, Cohen A, Thevenot P. 03:45 PM Abstract No. 213 Synthetic liver function and absolute lymphocyte count are associated with tumor response to locoregional therapy as well as immunosuppressive cell populations in transplant waitlist patients with hepatocellular carcinoma: single-center, prospective, observational trial Journal of Vascular and Interventional Radiology. 30. DOI: 10.1016/J.Jvir.2018.12.270  0.33
2019 Nunez KG, Sandow T, Robertson S, Cohen AJ, Thevenot PT. Liver functional reserve and pre-treatment immune tolerance in waitlist treatment naïve HCC patients is associated with poor tumor response to locoregional therapy Hpb. 21. DOI: 10.1016/J.Hpb.2019.03.188  0.301
2017 Sandow TA, Arndt SE, Albar AA, DeVun DA, Kirsch DS, Gimenez JM, Bohorquez HE, Gilbert PJ, Thevenot PT, Nunez KG, Galliano GA, Cohen AJ, Kay D, Gulotta PM. Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort. Radiology. 170731. PMID 29206595 DOI: 10.1148/Radiol.2017170731  0.327
2016 Raber PL, Sierra RA, Thevenot PT, Shuzhong Z, Wyczechowska DD, Kumai T, Celis E, Rodriguez PC. T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy. Oncotarget. PMID 27007050 DOI: 10.18632/Oncotarget.8197  0.343
2015 Fletcher M, Ramirez ME, Sierra RA, Raber P, Thevenot P, Al-Khami AA, Sanchez-Pino D, Hernandez C, Wyczechowska DD, Ochoa AC, Rodriguez PC. l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells. Cancer Research. 75: 275-83. PMID 25406192 DOI: 10.1158/0008-5472.Can-14-1491  0.349
2015 Raber P, Thevenot P, Sierra R, Rodriguez PC. Antigen-specific T cells conditioned with MDSC display a surprising increased anti-tumor activity after adoptive T cell-based immunotherapy Journal For Immunotherapy of Cancer. 3: P413. DOI: 10.1186/2051-1426-3-S2-P413  0.34
2014 Thevenot PT, Sierra RA, Raber PL, Al-Khami AA, Trillo-Tinoco J, Zarreii P, Ochoa AC, Cui Y, Del Valle L, Rodriguez PC. The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors. Immunity. 41: 389-401. PMID 25238096 DOI: 10.1016/J.Immuni.2014.08.015  0.343
2014 Sierra RA, Thevenot P, Raber PL, Cui Y, Parsons C, Ochoa AC, Trillo-Tinoco J, Del Valle L, Rodriguez PC. Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer. Cancer Immunology Research. 2: 800-11. PMID 24830414 DOI: 10.1158/2326-6066.Cir-14-0021  0.333
2014 Raber PL, Thevenot P, Sierra R, Wyczechowska D, Halle D, Ramirez ME, Ochoa AC, Fletcher M, Velasco C, Wilk A, Reiss K, Rodriguez PC. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. International Journal of Cancer. Journal International Du Cancer. 134: 2853-64. PMID 24259296 DOI: 10.1002/Ijc.28622  0.335
2013 Raber PL, Thevenot P, Sierra R, Wyczechowska D, Ramirez ME, Ochoa A, Velasco C, Rodriguez PC. Independent mechanisms of T cell-suppression by subpopulations of myeloid-derived suppressor cells (MDSC) in tumor-bearing hosts Journal For Immunotherapy of Cancer. 1: P193. DOI: 10.1186/2051-1426-1-S1-P193  0.363
2011 Thevenot PT, Baker DW, Weng H, Sun MW, Tang L. The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials. Biomaterials. 32: 8394-403. PMID 21864899 DOI: 10.1016/J.Biomaterials.2011.07.084  0.536
2011 Wang P, Thevenot P, Saravia J, Ahlert T, Cormier SA. Radical-containing particles activate dendritic cells and enhance Th17 inflammation in a mouse model of asthma. American Journal of Respiratory Cell and Molecular Biology. 45: 977-83. PMID 21493781 DOI: 10.1165/Rcmb.2011-0001Oc  0.302
2010 Tran RT, Thevenot P, Gyawali D, Chiao JC, Tang L, Yang J. Synthesis and characterization of a biodegradable elastomer featuring a dual crosslinking mechanism. Soft Matter. 6: 2449-2461. PMID 22162975 DOI: 10.1039/C001605E  0.522
2010 Tran RT, Thevenot P, Zhang Y, Gyawali D, Tang L, Yang J. Scaffold Sheet Design Strategy for Soft Tissue Engineering. Nature Materials. 3: 1375-1389. PMID 21113339 DOI: 10.3390/Ma3021375  0.543
2010 Sohaebuddin SK, Thevenot PT, Baker D, Eaton JW, Tang L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Particle and Fibre Toxicology. 7: 22. PMID 20727197 DOI: 10.1186/1743-8977-7-22  0.523
2010 Thevenot PT, Nair AM, Shen J, Lotfi P, Ko CY, Tang L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials. 31: 3997-4008. PMID 20185171 DOI: 10.1016/J.Biomaterials.2010.01.144  0.698
2010 Nair A, Thevenot P, Dey J, Shen J, Sun MW, Yang J, Tang L. Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Engineering. Part C, Methods. 16: 23-32. PMID 19327002 DOI: 10.1089/Ten.Tec.2009.0094  0.615
2008 Thevenot P, Sohaebuddin S, Poudyal N, Liu JP, Tang L. Magnetic Nanoparticles to Enhance Cell Seeding and Distribution in Tissue Engineering Scaffolds. Proceedings of the ... Ieee Conference On Nanotechnology / Co-Sponsored by Ieee Robotics and Automation Society (Ras) ... [Et Al.]. Ieee Conference On Nanotechnology. 2008: 646-649. PMID 22348179 DOI: 10.1109/NANO.2008.196  0.478
2008 Nair A, Shen J, Thevenot P, Cai T, Hu Z, Tang L. Novel Quantum Dots for Enhanced Tumor Imaging. Proceedings of the ... Ieee Conference On Nanotechnology / Co-Sponsored by Ieee Robotics and Automation Society (Ras) ... [Et Al.]. Ieee Conference On Nanotechnology. 8: 650-653. PMID 22267976 DOI: 10.1109/NANO.2008.197  0.597
2008 Nair A, Shen J, Thevenot P, Zou L, Cai T, Hu Z, Tang L. Enhanced intratumoral uptake of quantum dots concealed within hydrogel nanoparticles. Nanotechnology. 19: 485102. PMID 21836292 DOI: 10.1088/0957-4484/19/48/485102  0.615
2008 Nair A, Thevenot P, Hu W, Tang L. NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS. Journal of Biomedical Nanotechnology. 4: 410-418. PMID 20668648 DOI: 10.1166/Jbn.2008.004  0.599
2008 Thevenot P, Nair A, Dey J, Yang J, Tang L. Method to analyze three-dimensional cell distribution and infiltration in degradable scaffolds. Tissue Engineering. Part C, Methods. 14: 319-31. PMID 19055358 DOI: 10.1089/Ten.Tec.2008.0221  0.636
2008 Dey J, Xu H, Shen J, Thevenot P, Gondi SR, Nguyen KT, Sumerlin BS, Tang L, Yang J. Development of biodegradable crosslinked urethane-doped polyester elastomers. Biomaterials. 29: 4637-49. PMID 18801566 DOI: 10.1016/J.Biomaterials.2008.08.020  0.496
2008 Thevenot P, Cho J, Wavhal D, Timmons RB, Tang L. Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomedicine : Nanotechnology, Biology, and Medicine. 4: 226-36. PMID 18502186 DOI: 10.1016/J.Nano.2008.04.001  0.509
2008 Thevenot P, Hu W, Tang L. Surface chemistry influences implant biocompatibility. Current Topics in Medicinal Chemistry. 8: 270-80. PMID 18393890 DOI: 10.2174/156802608783790901  0.501
Show low-probability matches.